AACC NEWS RELEASE
FOR IMMEDIATE RELEASE
Contact: Peter Patterson
(202) 835-8718
800-892-1400 ext. 1718
Email: ppatterson@aacc.org


Thursday, February 17, 2011
AACC’s 2011 Oak Ridge Conference to Feature Keynote Address From Dr. Bernard Branson of The CDC

Washington, DC, February 17, 2011     The American Association for Clinical Chemistry (AACC) announces its 43rd Oak Ridge Conference being held April 14 – 15, 2011, at the Renaissance Baltimore Harborplace Hotel in Baltimore, MD.

The Oak Ridge Conference is the AACC’s annual forum for emerging clinical diagnostic technologies. With presentations focusing on novel technologies and systems, the meeting brings together thought leaders from industry, academia, and clinical laboratories. The conference focuses exclusively on pre-commercial technologies, and session topics are updated each year to reflect diagnostic trends. Now in its 43rd year, the Oak Ridge Conference is firmly established as the premier forum for next generation clinical diagnostics developers. The topic for the 2011 conference is Emerging Technologies for 21st Century Clinical Diagnostics. The Keynote Presentation on Thursday, April 14, is Evolution of HIV Diagnostic Testing and Continuing Challenges by Bernard Branson, MD from the Centers for Disease Control & Prevention in Atlanta, GA. Since the discovery of HIV 25 years ago, diagnostic technologies have had a major impact on management of infected individuals both clinically and epidemiologically. Dr. Branson will provide an overview of the history of serologic diagnosis of HIV infection, and he will discuss continuing challenges in the field, including the need for: testing for incidence and recent infection; more accessible viral load tests; identifying acute infection; and improved confirmatory tests.

The conference consists of two sessions on April 14: New Technologies for Infectious Disease Diagnostics and New Technologies for Quantitative Pathway Mapping in Tissues and Cells. Sessions III and IV, to be held on April 15 are New Sequencing Technologies for Clinical Diagnostics and Novel Nanotechnology Approaches for Diagnostics respectively. A detailed program for the conference is available here.

The conference is expected to attract 250-300 attendees from major and start-up diagnostic companies, hospital and reference labs, and academic research labs. AACC is pleased to offer complimentary press registrations to journalists reporting on the future of clinical diagnostics. To apply, complete and return a Press Registration Form. For more information about the conference or AACC, contact Peter Patterson on either of the above phone numbers or at ppatterson@aacc.org.

# # # # #

AACC is a leading professional society dedicated to improving healthcare through laboratory medicine. Its over 9,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations. AACC brings this community together with programs that advance knowledge, expertise, and innovation.